The Bon-Ton Stores, Inc. Announces Third Quarter Fiscal

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The Bon-Ton Stores, Inc. Announces Third Quarter Fiscal 2015 Results

YORK, Pa., Nov. 19, 2015 (GLOBE NEWSWIRE) -- The Bon-Ton Stores, Inc. (NASDAQ: BONT ) today reported operating results for the third quarter of fiscal 2015, the 13-week period ended October 31, 2015.

Third Quarter Overview

  • Comparable store sales decreased 2.6% in the third quarter as compared with the prior year period.
  • Gross margin rate decreased 286 basis points as compared with last year to 33.4% of net sales in the current year period.
  • Selling, general and administrative ("SG&A") expense decreased $0.7 million in the third quarter compared with the prior year period.
  • Adjusted EBITDA was $5.7 million in the third quarter of fiscal 2015. (Adjusted EBITDA is not a measure recognized under generally accepted accounting principles – see Note 1.) Adjusted EBITDA was $28.4 million in the third quarter of fiscal 2014.
  • Net loss in the third quarter of fiscal 2015 was $34.0 million, or $1.72 per diluted share, compared with net loss of $11.0 million, or $0.57 per diluted share, in the third quarter of fiscal 2014.
  • The Company completed a $75 million accordion exercise on August 28 and, subsequent to the third quarter of fiscal 2015, completed a second transaction of $80 million that cumulatively expanded its borrowing capabilities under its revolving credit facility by $155 million, bringing total revolving commitments to $830 million.

Comments

Kathryn Bufano, President and Chief Executive Officer, commented, "Clearly, our third quarter results were challenged as sales were pressured by unseasonably warm weather, which significantly impacted our cold-weather classifications, and by continued weakness in overall traffic trends. However, customers strongly responded to our expanded brand offerings and we also saw sustained momentum in certain core categories. Recognizing that the competitive environment is likely to continue, we remain focused on creating a differentiated and compelling product assortment and leveraging our home town strategy. We also continued to control our expenses, resulting in a net reduction in SG&A in the period. We ended the quarter in a healthy inventory position in terms of freshness and content, primed for holiday selling. Additionally, as previously announced, we amended our private label credit card agreement, extending a valued and successful partnership three years to 2022." 

Ms. Bufano continued, "Looking ahead, we are not anticipating major changes in the retail environment in the near term. Accordingly, we are pursuing a number of avenues to drive additional process improvements and further reduce expenses." The Company's plan is expected to yield approximately $35 million in annual savings in fiscal 2016. These expense savings, which will benefit SG&A expenses and gross margin, combined with lower capital spending and inventory levels, will positively impact 2016 cash flow.

Third Quarter Details

Comparable store sales in the third quarter of fiscal 2015 decreased 2.6%. Total sales in the period decreased 3.0% to $623.4 million, compared with $642.7 million in the third quarter of fiscal 2014.  Sales were adversely impacted by unseasonably warm weather and the continuation of soft traffic trends. Despite these challenges, we achieved a 3.0% increase in sales associated with our proprietary credit card and sales growth in eCommerce, primarily due to a higher conversion rate.  The sales performance in our small and mid-tier stores continued to outpace that of our larger locations. Year-to-date fiscal 2015 comparable store sales decreased 1.0%.     

Other income in the third quarter of fiscal 2015 was $17.5 million, compared with $16.0 million in the third quarter of fiscal 2014. The increase was largely the result of increased revenues associated with our proprietary credit card operations. Proprietary credit card sales, as a percentage of total sales, increased 299 basis points to 54.5% in the third quarter of fiscal 2015.

The gross margin rate in the third quarter of fiscal 2015 decreased 286 basis points as compared with the third quarter of fiscal 2014 to 33.4% of net sales, largely the result of increased net markdowns and increased distribution and delivery costs associated with omnichannel selling efforts in the current quarter. Gross profit decreased $24.9 million to $208.4 million in the third quarter of fiscal 2015 as a result of both decreased sales volume and rate in the period.  

In the third quarter of fiscal 2015, SG&A expense was $220.2 million, a decrease of $0.7 million from the third quarter of fiscal 2014 results. This reduction was largely driven by expense control measures as well as the avoidance of costs incurred in the prior year related to the implementation of our expense efficiency initiative, partially offset by increased advertising expenses and continued investment in omnichannel operations. SG&A expense rate increased 95 basis points to 35.3% of net sales in the third quarter of fiscal 2015 as a result of the decreased sales volume in the period.   

The Company's excess borrowing capacity under its revolving credit facility, which includes the $75 million increase as a result of the accordion exercise completed on August 28, was $250.2 million at the end of the third quarter of fiscal 2015.

The Company's Board of Directors did not declare a dividend at this time as a result of the current shareholders' deficit and the requirements of Pennsylvania state law. The Board of Directors will revisit the declaration of a dividend at the end of fiscal 2015.   

Guidance     

For fiscal 2015, the Company now expects Adjusted EBITDA in a range of $110 million to $120 million. Earnings per diluted share are expected to be in a range of a loss of $2.15 to $2.65 and cash flow (see Note 2) is now expected to be in a range of ($30) million to ($40) million.

Assumptions reflected in our full-year guidance include the following:   

  • A  comparable store sales performance ranging from a decrease of 0.5% to 1.5%;  
  • A gross margin rate ranging from a decrease of 70 to 80 basis points from the fiscal 2014 rate of 35.7%;
  • An SG&A expense rate ranging from a 30- to 60-basis-point increase over the fiscal 2014 rate of 32.9%;
  • Capital expenditures not to exceed $71 million, net of external contributions; and
  • An estimated 20 million average diluted shares outstanding.

Guidance does not reflect any potential impact associated with an early termination of the Company's remaining mortgage facility, thereby excluding the financial effect of the make-whole provision in the agreement, which could range up to approximately $2 million. It also does not include any implementation costs associated with the planned expense reductions in fiscal 2016, as those costs have yet to be determined. 

Call Details

The Company's quarterly conference call discussing its third quarter fiscal 2015 results will be broadcast live today at 10:00 a.m. Eastern time. Investors and analysts interested in participating in the call are invited to dial (888) 211-4434 at 9:55 a.m. Eastern time and reference conference ID 4537346. A taped replay of the conference call will be available within two hours of the conclusion of the call and will remain available through Thursday, November 26, 2015. The number to call for the taped replay is (877) 870-5176 and the replay PIN is 4537346. The conference call will also be broadcast on the Company's website at http://investors.bonton.com . An online archive of the webcast will be available within two hours of the conclusion of the call.

About The Bon-Ton Stores, Inc.

The Bon-Ton Stores, Inc., with corporate headquarters in York, Pennsylvania and Milwaukee, Wisconsin, operates 270 stores, which includes nine furniture galleries and four clearance centers, in 26 states in the Northeast, Midwest and upper Great Plains under the Bon-Ton, Bergner's, Boston Store, Carson's, Elder-Beerman, Herberger's and Younkers nameplates. The stores offer a broad assortment of national and private brand fashion apparel and accessories for women, men and children, as well as cosmetics and home furnishings. For further information, please visit the investor relations section of the Company's website at http://investors.bonton.com .  

Cautionary Note Regarding Forward-Looking Statements

Certain information included in this press release contains statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, which may be identified by words such as "may," "could," "will," "plan," "expect," "anticipate," "estimate," "project," "intend" or other similar expressions and include the Company's fiscal 2015 guidance, involve important risks and uncertainties that could significantly affect results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of the Company.   Factors that could cause such differences include, but are not limited to: risks related to retail businesses generally; a significant and prolonged deterioration of general economic conditions which could negatively impact the Company in a number of ways, including the potential write-down of the current valuation of intangible assets and deferred taxes; risks related to the Company's proprietary credit card program; potential increases in pension obligations; consumer spending patterns, debt levels, and the availability and cost of consumer credit; additional competition from existing and new competitors or changes in the competitive environment; inflation; deflation; changes in the costs of fuel and other energy and transportation costs; weather conditions that could negatively impact sales; uncertainties associated with expanding or remodeling existing stores; the ability to attract and retain qualified management; the dependence upon relationships with vendors and their factors; a data security breach or system failure; the ability to reduce or control SG&A expenses, including initiatives to reduce expenses and improve efficiency; operational disruptions; unsuccessful marketing initiatives; the ability to expand our capacity and improve efficiency through our new eCommerce fulfillment center; changes in, or the failure to successfully implement, our key strategies, including initiatives to improve our merchandising, marketing and operations; adverse outcomes in litigation; the incurrence of unplanned capital expenditures; the ability to obtain financing for working capital, capital expenditures and general corporate purposes; the impact of regulatory requirements including the Health Care Reform Act and the Dodd-Frank Wall Street Reform and Consumer Protection Act; the inability or limitations on the Company's ability to favorably adjust the valuation allowance on deferred tax assets; and the financial condition of mall operators. Additional factors that could cause the Company's actual results to differ from those contained in these forward-looking statements are discussed in greater detail under Item 1A of the Company's Form 10-K filed with the Securities and Exchange Commission.

Note 1: As used in this release, Adjusted EBITDA is defined as earnings before interest, income taxes, depreciation and amortization, including amortization of lease-related interests, impairment charges and loss on extinguishment of debt. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles ("GAAP"). However, we present Adjusted EBITDA in this release because we consider it to be an important supplemental measure of our performance and because it is frequently used by securities analysts, investors and other interested parties to evaluate the performance of companies in our industry and by some investors to determine a company's ability to service or incur debt. In addition, our management uses Adjusted EBITDA internally to compare the profitability of our stores. Adjusted EBITDA is not calculated in the same manner by all companies and, accordingly, is not necessarily comparable to similarly entitled measures of other companies and may not be an appropriate measure for performance relative to other companies. Adjusted EBITDA should not be assessed in isolation from or construed as a substitute for net income or cash flows from operations, which are prepared in accordance with GAAP. Adjusted EBITDA is not intended to represent, and should not be considered to be a more meaningful measure than, or an alternative to, measures of operating performance as determined in accordance with GAAP. A reconciliation of net loss to Adjusted EBITDA is provided in the financial schedules accompanying this release. 

 Note 2: As used in this release, cash flow reflects the forecasted net loss, plus depreciation and amortization, amortization of lease-related interests and impairment charges, less capital expenditures and pension contributions. 

– tables follow –

THE BON-TON STORES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
       
(In thousands, except share and per share data)   October 31, November 1,
(Unaudited)   2015 2014
       
Assets      
Current assets:      
Cash and cash equivalents    $ 21,667  $ 7,516
Merchandise inventories    994,482  970,649
Prepaid expenses and other current assets    82,647  79,059
Total current assets    1,098,796  1,057,224
Property, fixtures and equipment at cost, net of accumulated depreciation and amortization of $951,138 and $922,608 at October 31, 2015 and November 1, 2014, respectively  643,511  637,217
Deferred income taxes    14,546  20,486
Intangible assets, net of accumulated amortization of $62,412 and $62,811 at October 31, 2015 and November 1, 2014, respectively  85,417  91,891
Other long-term assets    23,031  23,162
Total assets    $ 1,865,301  $ 1,829,980
       
Liabilities and Shareholders' (Deficit) Equity      
Current liabilities:      
Accounts payable    $ 362,042  $ 376,070
Accrued payroll and benefits    21,353  24,248
Accrued expenses    154,831  157,462
Current maturities of long-term debt     102,997  7,286
Current maturities of obligations under capital leases  5,262  3,888
Deferred income taxes     24,589  28,784
Total current liabilities    671,074  597,738
Long-term debt, less current maturities    902,647  971,608
Obligations under capital leases, less current maturities  128,089  46,034
Other long-term liabilities    181,286  165,897
Total liabilities    1,883,096  1,781,277
       
Shareholders' (deficit) equity:      
Preferred Stock - authorized 5,000,000 shares at $0.01 par value; no shares issued   --   -- 
Common Stock - authorized 40,000,000 shares at $0.01 par value; issued shares of 18,343,527 and 17,818,323 at October 31, 2015 and November 1, 2014, respectively  183  178
Class A Common Stock - authorized 20,000,000 shares at $0.01 par value; issued and outstanding shares of 2,951,490 at October 31, 2015 and November 1, 2014  30  30
Treasury stock, at cost - 337,800 shares at October 31, 2015 and November 1, 2014   (1,387)  (1,387)
Additional paid-in-capital    163,747  160,759
Accumulated other comprehensive loss     (77,573)  (48,006)
Accumulated deficit    (102,795)  (62,871)
Total shareholders' (deficit) equity    (17,795)  48,703
Total liabilities and shareholders' (deficit) equity  $ 1,865,301  $ 1,829,980
 
 
THE BON-TON STORES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
         
         
  THIRTEEN THIRTY-NINE
  WEEKS ENDED WEEKS ENDED
(In thousands, except per share data) October 31, November 1, October 31, November 1,
(Unaudited) 2015 2014 2015 2014
         
Net sales  $ 623,400  $ 642,735  $ 1,789,769  $ 1,813,647
Other income  17,497  16,022  49,369  45,780
   640,897  658,757  1,839,138  1,859,427
         
Costs and expenses:      
Costs of merchandise sold  415,025  409,484  1,170,318  1,159,846
Selling, general and administrative  220,183  220,901  654,055  659,027
Gain on insurance recovery  --   --   (748)  -- 
Depreciation and amortization  22,786  22,073  69,012  67,678
Amortization of lease-related interests  1,045  1,101  3,207  3,442
Impairment charges  203  273  425  447
(Loss) income from operations  (18,345)  4,925  (57,131)  (31,013)
Interest expense, net  15,846  15,506  46,232  46,224
Loss on extinguishment of debt  --   --   4,862  153
         
Loss before income taxes   (34,191)  (10,581)  (108,225)  (77,390)
Income tax (benefit) provision   (199)  427  (596)  1,322
         
Net loss  $ (33,992)  $ (11,008)  $ (107,629)  $ (78,712)
         
Basic loss per share  $ (1.72)  $ (0.57)  $ (5.47)  $ (4.06)
         
         
Diluted loss per share  $ (1.72)  $ (0.57)  $ (5.47)  $ (4.06)
         
         
Other financial data:      
Adjusted EBITDA (1)  $ 5,689  $ 28,372  $ 15,513  $ 40,554
         

(1)    Adjusted EBITDA reconciliation

      The following table reconciles net loss to Adjusted EBITDA for the periods indicated:

     
  THIRTEEN THIRTY-NINE
  WEEKS ENDED WEEKS ENDED
(In thousands) October 31, November 1, October 31, November 1,
(Unaudited) 2015 2014 2015 2014
         
Net loss  $ (33,992)  $ (11,008)  $ (107,629)  $ (78,712)
Adjustments:        
Income tax (benefit) provision   (199)  427  (596)  1,322
Loss on extinguishment of debt  --   --   4,862  153
Interest expense, net  15,846  15,506  46,232  46,224
Depreciation and amortization  22,786  22,073  69,012  67,678
Amortization of lease-related interests  1,045  1,101  3,207  3,442
Impairment charges  203  273  425  447
Adjusted EBITDA  $ 5,689  $ 28,372  $ 15,513  $ 40,554

Kim George Divisional Vice President Investor Relations 717.751.3071

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 307

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 246

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 694

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 180

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

b1BANK Partners with Spiral to Enhance Community Banking Impact

Updated Category News Views 97

Enhanced Financial Wellness through Partnership NEW YORK--Today, Spiral, a personalized banking platform, announced a significant partnership with b1BANK, established as a community-focused banking institution. Through this collaboration, the two organizations aim to enhance financial wellness for customers, leveraging b1BANK's dedication to innovative banking solutions...

Continue Reading
AM Best Explores Trends Influencing For-Hire Trucking Industry

Updated Category News Views 168

Insights from AM Best's Latest Webinar on Trucking Trends Viewers can now delve into the highlights from the enlightening webinar hosted by AM Best, titled "For-Hire Trucking: The Risky Road Ahead." This event focused on the intricacies and challenges within the transportation-for-hire trucking sector, providing expert insights into risk management strategies and the...

Continue Reading
BitMart's Creative Campaign to Ignite Offline Crypto Engagement

Updated Category News Views 135

Introducing the Fox Hunt Delivery Campaign BitMart, a leading global cryptocurrency exchange, is excited to announce the launch of the Fox Hunt Delivery Campaign, a unique initiative aimed at boosting cryptocurrency adoption through engaging offline activities. This campaign offers an exciting chance for participants to earn USDT rewards simply by introducing new users to...

Continue Reading
Trinity Capital Inc. Fuels Alt Platform's Growth with $40M Credit

Updated Category News Views 273

Trinity Capital Inc. Supports Alt with Significant Credit Facility Trinity Capital Inc. (NASDAQ: TRIN), a prominent alternative asset manager, is thrilled to announce a groundbreaking agreement with Alt, providing up to $40 million through an asset-based revolving credit facility. This funding aims to bolster Alt's innovative marketplace tailored for trading card...

Continue Reading
Everest Medicines Achieves Record Revenue and Growth in 2024

Updated Category News Views 506

Everest Medicines Achieves Remarkable Financial Success Everest Medicines, a groundbreaking biopharmaceutical company focused on innovative healthcare solutions, has reported remarkable financial results for the year ending December 31, 2024. With a robust revenue growth of 461%, the company stands out in the pharmaceutical industry, showcasing its resilience and dynamic...

Continue Reading